Komori
Changes in Officers4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Our Subsidiary: キョーリン製薬グループ工場株式会社 — Notice Regarding Changes in Officers

Fukuda Mamoru (福田守), a director of the subsidiary, will also oversee the Reliability Assurance Department in addition to serving as Head of the Production Control Division. The effective date is 1 November 2026.

Worth reading
17Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Incoming appointee

1 item
Scheduled Appointment Date1 November 2026
Fukuda Mamoru (福田 守)
Previous positionDirector, Head of the Production Control Division
New positionDirector, overseeing the Reliability Assurance Department
Who is moving to which position
ItemDetails
Scheduled Appointment Date1 November 2026
Name of appointeeFukuda Mamoru (福田 守)
Appointee's new positionDirector, overseeing the Reliability Assurance Department
Appointee's previous positionDirector, Head of the Production Control Division
Items this document does not state (17)
Resolution dateDate of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for the personnel change is not stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Our Subsidiary: キョーリン製薬グループ工場株式会社 — Notice Regarding Changes in Officers | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori